The involvement of inositol 1,4,5-trisphosphate (IP 3 ) formation in the voltage-dependent regulation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) was examined in smooth muscle cells of the porcine coronary artery. Slow ramp depolarization from Ϫ90 to 0 mV induced progressive [Ca 2ϩ ] i increase. The slope was reduced or increased in the presence of Cd 
Introduction
Smooth muscle cells (SMCs) in large coronary arteries have relatively low membrane excitability under physiological conditions, because of their low expression level of the voltage-dependent Ca 2ϩ channel (VDCC) (Kuriyama et al., 1998; Yamamura et al., 1999) . Membrane hyperpolarization in vascular SMCs (VSMCs), induced by an application of ATP-sensitive K ϩ (K ATP ) channel openers, results in a decrease in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), presumably because of the suppression of VDCC activity (Quayle et al., 1997) . Another potential mechanism for the decrease in [Ca 2ϩ ] i induced by K ATP channel openers has been suggested to be as follows. The membrane hyperpolarization suppresses the phospholipase C (PLC) activity required for inositol 1,4,5-trisphosphate (IP 3 ) formation in rabbit mesenteric arterial SMCs (Itoh et al., 1992) . The elevated PLC activity that occurred during the stimulation of G protein-coupled receptors with an agonist may be voltage-sensitive. It has been shown in guinea pig coronary arterial SMCs (CASMCs) that ABBREVIATIONS: SMC, smooth muscle cell; CASMC, coronary arterial SMC; VSMC, vascular SMC; 2-APB, 2-aminoethoxydiphenylborate; [Ca 2ϩ ] i , intracellular Ca 2ϩ concentration; DMSO, dimethyl sulfoxide; indo-1/AM, indo-1/acetoxymethyl ester; IP 3 , inositol 1,4,5-trisphosphate; IP 3 R, IP 3 receptor; K ATP channel, ATP-sensitive K ϩ channel; PLC, phospholipase C; RyR, ryanodine receptor; SR, sarcoplasmic reticulum; VDCC, voltage-dependent Ca 2ϩ channel; Bay K 8644, (Ϯ)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]-phenyl)pyridine-3-carboxylic acid methyl ester; U73122, 1-[6-[((17␤)-3-methoxyestra-1,3,5 [10]-trien-17-yl)amino]hexyl]-1H-pyrrole-2,5-dione; NS-1619, 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one; K Ca 1.1/BK Ca channel, large-conductance Ca 2ϩ -activated K ϩ channel.
the membrane hyperpolarization induced by a command pulse under voltage clamp reduces the [Ca 2ϩ ] i , which is elevated in the presence of an agonist. This phenomenon was also observed in the absence of Ca 2ϩ influx, but only in the presence of agonist, strongly suggesting that the PLC activated by agonist stimulation is voltage-dependent in guinea pig CASMCs (Ganitkevich and Isenberg, 1993) .
IP 3 is a key second messenger that regulates many important physiological functions. The hydrolysis of phosphatidylinositol 4,5-bisphosphate catalyzed by PLC produces IP 3 , which results in the release of Ca 2ϩ from the sarcoplasmic reticulum (SR) through the IP 3 R (Berridge, 1993; Clapham, 1995; Berridge et al., 2003) . The phosphoinositide-specific superfamily of PLC enzymes has been classified into four isoforms: ␤, ␥, ␦, and ε (Rhee and Bae, 1997; Lymn and Hughes, 2000; Rhee, 2001) . Among these isoforms, PLC␤ is functionally coupled to heterotrimeric G proteins in response to agonist and is responsible for the generation of IP 3 from phosphatidylinositol 4,5-bisphosphate (Berridge, 1993; Somlyo and Somlyo, 1994) . The PLC␤ protein is expressed in VSMCs (Lymn and Hughes, 2000; LaBelle et al., 2002) , including the aorta (Blayney et al., 1996 (Blayney et al., , 1998 Cueille et al., 2003; Ocharan et al., 2005) , renal artery (Blayney et al., 1998) , tail artery (LaBelle et al., 2002) , and coronary artery (Cueille et al., 2003; Ansari et al., 2009) .
Direct visualization of IP 3 in murine Purkinje cells has shown that membrane depolarization itself facilitates the formation of IP 3 , and this depends on Ca 2ϩ influx and depolarization (Okubo et al., 2001) . In contrast to the results in VSMCs (Ganitkevich and Isenberg, 1993) , the preceding activation of PLC by an agonist is not required for the depolarization-induced enhancement of IP 3 formation in neurons (Okubo et al., 2001 ). This striking observation indicates that Ca 2ϩ -induced IP 3 formation and subsequent Ca 2ϩ release from internal Ca 2ϩ stores is functional in neurons. However, there seems to be a discrepancy between the results in VSMCs and neurons, because the [Ca 2ϩ ] i was independent of the voltage status when the [Ca 2ϩ ] i was elevated by caffeine in guinea pig CASMCs (Ganitkevich and Isenberg, 1993) . It was reported that, in the absence of exogenous agonists, membrane depolarization directly activates muscarinic M 3 receptors, which induces the activation of G q proteins and PLC and subsequent IP 3 generation in mouse tracheal SMCs. This direct activation induces an increase in local Ca 2ϩ release, Ca 2ϩ spark, and contraction in mouse tracheal SMCs (Liu et al., 2009 ). In addition, the VDCC activation and subsequent metabolic Ca 2ϩ release that involves G protein/ PLC activation, IP 3 synthesis, and Ca 2ϩ release from the SR participate in the sustained arterial contraction through depolarization-evoked RhoA/Rho-associated kinase activity in the VSMCs. These phenomena are independent of the change in the membrane potential itself, or the mere release of Ca 2ϩ from the SR, and require the simultaneous activation of VDCC and the downstream metabotropic pathway with concomitant Ca 2ϩ release (Ferná ndez-Tenorio et al., 2011 ). The present study was undertaken to elucidate whether IP 3 -induced Ca 2ϩ release takes place during depolarization in the absence of receptor stimulation by an agonist in porcine CASMCs, using two-dimensional confocal Ca 2ϩ imaging analysis under voltage clamp. To inhibit IP 3 -induced Ca 2ϩ release, heparin, 2-aminoethoxydiphenylborate (2-APB), and xestospongin C, which block IP 3 binding to receptors in the SR, [1] [2] [3] [4] [5] [6] 3, 5[10] -trien-17-yl) amino]hexyl]-1H-pyrrole-2,5-dione (U73122), an inhibitor of PLC, were added to the cytoplasm by using recording pipettes. These results constitute evidence in support of the notion that IP 3 production is facilitated during prolonged depolarization in the absence of agonist stimulation, but it requires a preceding increase in [Ca 2ϩ ] i and corresponding outward currents in CASMCs.
Materials and Methods
Ethical Approval. All experiments were approved by the Ethics Committee of Nagoya City University and conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the Japanese Pharmacological Society.
Cell Isolation. Single SMCs from a porcine coronary artery were prepared as described previously . In brief, whole hearts of 6-month-old young pigs were obtained from a local slaughterhouse (Nagoya Meat Market, Nagoya, Japan). Small pieces of the left circumflex coronary artery were dissected, cleaned of blood and surrounding tissues, and immersed for 40 min in Ca 2ϩ -free Krebs' solution containing 0.2% collagenase (Amano Enzyme, Nagoya, Japan), 1.0% albumin (bovine, fraction V; Seikagaku Kogyo, Tokyo, Japan), 0.1% papain (Sigma-Aldrich, St. Louis, MO), and 0.2% trypsin inhibitor (Sigma-Aldrich) at 37°C. After this incubation, the solution was replaced with Ca 2ϩ -and collagenase-free Krebs' solution. Cells were isolated by gentle agitation with a glass pipette, and a few drops of cell suspension were placed in a recording chamber. After these cells had settled, the recording chamber was continuously perfused with the HEPES-buffered solution at a flow rate of 2 ml/min.
Solutions. The Ca 2ϩ -free Krebs' solution had an ionic composition of 112 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , and 14 mM glucose. The pH was adjusted to 7.4 by gassing with a mixture of 95% O 2 and 5% CO 2 . The HEPES-buffered solution for electrophysiological recording had an ionic composition of 137 mM NaCl, 5.9 mM KCl, 2.2 mM CaCl 2 , 1.2 mM MgCl 2 , 14 mM glucose, and 10 mM HEPES. The pH was adjusted to 7.4 with 10 N NaOH. The pipette solution contained 140 mM KCl, 1 mM MgCl 2 , 10 mM HEPES, and 2 mM Na 2 ATP. The pH was adjusted to 7.2 with 1 N KOH. A Ca 2ϩ fluorescence indicator was also added to the pipette solution as described below.
Electrophysiological Experiments. Electrophysiological studies were performed in single SMCs, using whole-cell patch-clamp configuration with a CEZ-2400 amplifier (Nihon Kohden, Tokyo, Japan). The electrophysiological recording procedures and data analysis were performed as described previously (Imaizumi et al., 1989) . All of the electrophysiological experiments were carried out at 30 Ϯ 1°C.
Confocal Ca 2؉ Imaging. Two-dimensional Ca 2ϩ images were obtained by using a fast scanning confocal fluorescent microscope (RCM-8000; Nikon, Tokyo, Japan) equipped with a Fluor 40ϫ, 1.15 NA objective lens (water immersion; Nikon), and Ratio3 software (Nikon) (Imaizumi et al., 1998; Yamamura et al., 2001 Yamamura et al., , 2002 . Freshly isolated myocytes were loaded with 100 M indo-1 (Dojin Laboratories, Kumamoto, Japan) by diffusion from the recording pipette for a few minutes. Indo-1 acetoxymethyl ester (indo-1/AM; Dojin Laboratories; 5 M) was loaded for 10 min without electrophysiological recording, and then removed for 10 min at room temperature (24 Ϯ 1°C). The argon ion laser excitation wavelength was 351 nm, and the emission wavelengths were 405 and 485 nm. The microscope resolution was 0.33 ϫ 0.27 m (one pixel) and 0.5 m in the z-axis direction. The Ca 2ϩ image was scanned over a full frame (512 ϫ 512 pixels age of five circles of 2-m diameter, which were located at the cell edge or in the center area, not including the nucleus, respectively. The calibration of the indo-1 signal was performed by a method reported previously (Grynkiewicz et al., 1985) . The data analysis was performed as described previously (Imaizumi et al., 1998; Yamamura et al., 2001) . Chemicals. Pharmacological reagents including Evans blue [(6,6Ј-[(3,3Ј-dimethyl-[1,1Ј-biphenyl [Ca 2ϩ ] i in the whole-cell area (as the global region) at Ϫ90 mV was 104 Ϯ 10 nM (n ϭ 7; Fig. 1, A and B) . The [Ca 2ϩ ] i was progressively increased by a slow ramp depolarization in a voltage-dependent manner and reached 390 Ϯ 21 nM at 0 mV (n ϭ 7). There was no significant difference between the peripheral and central [Ca 2ϩ ] i levels observed at any of the potentials examined. Voltage-dependent outward currents, which were primarily composed of large-conductance Ca 2ϩ -activated K ϩ (K Ca 1.1 or BK Ca ) channel currents and voltagedependent K ϩ channel currents, were simultaneously observed during the ramp pulse .
In the presence of 100 M Cd 2ϩ , which completely blocked VDCCs, the increase in the [Ca 2ϩ ] i evoked by the ramp depolarization was significantly reduced at potentials positive to Ϫ40 mV (p Ͻ 0.05 versus control). The [Ca 2ϩ ] i rise at 0 mV was reduced by approximately 80% in the presence of ] i and the membrane potential were performed by using a confocal microscope with 100 M indo-1 under whole-cell voltage clamp in porcine CASMCs. A slow ramp pulse from Ϫ90 to 0 mV was applied for 0.67 mV/s. A, typical Ca 2ϩ images of a myocyte were obtained as the average of sequential eight images for 264 ms (33 ms for each) at the potentials indicated. B, the global [Ca 2ϩ ] i was defined as the average [Ca 2ϩ ] i in the whole-cell area. The peripheral [Ca 2ϩ ] i was measured as the average of five circles of 2-m diameter, which were located at the cell edge, whereas the central [Ca 2ϩ ] i was measured as the average in an area Ͼ2 m away from the cell edge and did not include the nucleus. The outward current amplitude at each potential is also plotted. C, in the presence of 100 M Cd jpet.aspetjournals.org Downloaded from cellular 2.2 mM Ca 2ϩ resulted in more severe inhibition of the [Ca 2ϩ ] i increase at 0 mV (by 95 Ϯ 2% reduction; n ϭ 5). On the other hand, in the presence of 1 M Bay K 8644, which is an activator of VDCCs, the [Ca 2ϩ ] i was increased significantly at potentials positive to Ϫ70 mV. The [Ca 2ϩ ] i in the absence and presence of Bay K 8644 at 0 mV was 388 Ϯ 5 and 561 Ϯ 55 nM (n ϭ 5; p Ͻ 0.01), respectively (Fig. 1D) ϩ channels by two different types of openers were determined by using the slow ramp pulse. Evans blue has been reported to activate K Ca 1.1 channels via an enhancement of the ␣-subunit (Hollywood et al., 1998; Wu et al., 1999; Yamada et al., 2001) . In preliminary experiments, it was confirmed that the application of 100 M Evans blue induced membrane hyperpolarization by 13.5 Ϯ 1.0 mV (n ϭ 3; p Ͻ 0.01 versus a resting membrane potential of Ϫ40.8 Ϯ 0.7 mV), which was abolished by the addition of 100 nM iberiotoxin (to Ϫ35.5 Ϯ 0.8 mV; n ϭ 3), a specific inhibitor of the K Ca 1.1 channel. The simultaneous measurement of [Ca 2ϩ ] i and the membrane potential under current clamp indicated that the average resting membrane potential and [Ca 2ϩ ] i were Ϫ43.4 Ϯ 2.6 mV and 154 Ϯ 9 nM, respectively, under the control conditions (n ϭ 4). The application of 100 M Evans blue caused the membrane hyperpolarization to Ϫ55.0 Ϯ 1.4 mV (n ϭ 4; p Ͻ 0.05 versus control) and, correspondingly, a decrease in the [Ca 2ϩ ] i to 119 Ϯ 11 nM (n ϭ 4; p Ͻ 0.05; Fig. 2 ). The effect of levcromakalim, an activator of the K ATP channel, was also examined under the same experimental conditions, except for the removal of 2 mM ATP in the pipette solution to enhance K ATP channel activity. The application of 10 M levcromakalim induced a membrane hyperpolarization of 13.3 Ϯ 1.0 mV (n ϭ 6; p Ͻ 0.01 versus resting of Ϫ42.3 Ϯ 1.8 mV). Levcromakalim-induced hyperpolarization was abolished by the exposure to 10 M glibenclamide (to Ϫ40.7 Ϯ 2.4 mV; n ϭ 6). In the simultaneous measurement of the membrane potential and [Ca 2ϩ ] i , the application of levcromakalim induced the hyperpolarization of myocytes from Ϫ44.4 Ϯ 0.9 to Ϫ57.8 Ϯ 0.6 mV (n ϭ 5; p Ͻ 0.01) and decreased the [Ca 2ϩ ] i from 152 Ϯ 8 to 119 Ϯ 14 nM (n ϭ 5; p Ͻ 0.05; Fig. 2C Fig. 1B , the relationship between [Ca 2ϩ ] i and the membrane potential was identical to that in their absence (n ϭ 4 for each; data not shown). These results confirm that the decrease in [Ca 2ϩ ] i by membrane hyperpolarization caused by the activation of K ϩ channels by these openers may be identical to that induced by hyperpolarization in a voltage-clamp configuration.
Moreover, in the presence of Bay K 8644, the effects of Evans blue and levcromakalim on [Ca 2ϩ ] i were examined by using 5 M indo-1/AM without the electrophysiological recording. The average [Ca 2ϩ ] i in the presence of 1 M Bay K 8644 was 239 Ϯ 10 nM (n ϭ 15; p Ͻ 0.01 versus control of 126 Ϯ 3 nM; Fig. 3, A and B) . By the addition of 100 M Evans blue [Ca 2ϩ ] i was reduced to 165 Ϯ 3 nM (n ϭ 15; p Ͻ 0.01), which then was returned to 202 Ϯ 6 nM by the further addition of 100 nM iberiotoxin (n ϭ 15; p Ͻ 0.01 versus Evans blue alone). Before the addition of 10 M levcromakalim the average [Ca 2ϩ ] i was 242 Ϯ 6 nM in the presence of Bay K 8644 (n ϭ 22; p Ͻ 0.01 versus control of 125 Ϯ 2 nM; Fig. 3 ] i and membrane hyperpolarization caused by the activation of K ϩ channels by two different types of openers was compared with the relationship determined by using the slow ramp pulse as described in Fig. 1 . A, under current-clamp mode, an application of 100 M Evans blue, a K Ca 1.1 channel opener, caused membrane hyperpolarization and a corresponding decrease in [Ca 2ϩ ] i . B, typical Ca 2ϩ images of a myocyte in the absence, presence, and the withdrawal of Evans blue are shown. C, the averaged data in the absence and presence of Evans blue are plotted. The effects of 10 M levcromakalim, a K ATP channel opener, were also examined in the same manner, and the accumulated data are plotted. The dotted line is the data obtained by the slow ramp depolarization in Fig. 1B (Fig. 4) . The global [Ca 2ϩ ] i at Ϫ40 mV was 187 Ϯ 1 nM (n ϭ 5). The membrane hyperpolarization from the holding potential of Ϫ40 to Ϫ80 mV caused a global [Ca 2ϩ ] i decrease to 108 Ϯ 6 nM with a decay time constant of 10.0 Ϯ 0.7 s (n ϭ 5). We analyzed quantitatively whether the [Ca 2ϩ ] i decrease during hyperpolarization occurred uniformly in CASMCs (Fig. 4, A-C) . At the holding potential of Ϫ40 mV the [Ca 2ϩ ] i in the central and peripheral regions was 184 Ϯ 5 and 190 Ϯ 2 nM, respectively (n ϭ 5; p Ͼ 0.05; Fig. 4D ). With hyperpolarization of the membrane from Ϫ40 to Ϫ80 mV for 30 s, the [Ca 2ϩ ] i in the central and peripheral regions was reduced to 105 Ϯ 11 and 104 Ϯ 8 nM (n ϭ 5; p Ͼ 0.05) with a decay time constant of 10.6 Ϯ 0.8 and 8.8 Ϯ 0.5 s, respectively (n ϭ 5; p Ͼ 0.05; Fig. 4E ). Ca 2ϩ images of CASMCs during hyperpolarization from 0 to Ϫ80 mV were also analyzed in the same manner as shown in Fig. 4 (Fig. 5) . When the membrane potential was held at 0 mV for 60 s, the global [Ca 2ϩ ] i was 390 Ϯ 17 nM (n ϭ 5). The hyperpolarization to Ϫ80 mV reduced the global [Ca 2ϩ ] i to 113 Ϯ 7 nM with a decay time constant of 8.0 Ϯ 0.3 s (n ϭ 5). The global [Ca 2ϩ ] i at 0 mV in the peripheral region was not significantly different from that in the central region (p Ͼ 0.05; Fig. 5D ). The decay time constant in the peripheral regions (6.7 Ϯ 0.3 s; n ϭ 5) was, however, significantly smaller than those of the global regions (n ϭ 5; p Ͻ 0.05) and central regions (8.6 Ϯ 0.5 s; n ϭ 5; p Ͻ 0.05) (Fig. 5E ). It is clear from the time constants and line-scan Ca 2ϩ image in Fig. 5C ] i induced by hyperpolarization from Ϫ40 to Ϫ80 mV was measured in the presence of 1 mg/ml heparin in the pipette solution, a blocker of IP 3 receptors (IP 3 Rs) (Fig. 6A) . The [Ca 2ϩ ] i at both Ϫ40 and Ϫ80 mV was unaffected by heparin (184 Ϯ 6 and 100 Ϯ 2 nM, respectively; n ϭ 4; p Ͼ 0.05 versus control of 177 Ϯ 9 and 106 Ϯ 11 nM; Fig. 6B ). The decrease in [Ca 2ϩ ] i was fitted by means of a single exponential function with the time constants of 10.7 Ϯ 1.1 s (n ϭ 4) and 10.6 Ϯ 1.4 s (n ϭ 4; p Ͼ 0.05) in the absence and presence of heparin, respectively (Fig. 6C ). In addition, there was no significant difference in the inward current amplitude between the control (152 Ϯ 14 pA; n ϭ 4) and heparin-treated cells (141 Ϯ 3 pA; n ϭ 4, p Ͼ 0.05) (Fig. 6D ). The addition of other blockers of IP 3 Rs, 50 M 2-APB or 10 M xestospongin C, in the pipette solution, did not affect the [Ca 2ϩ ] i , decay time constant or current amplitude (n ϭ 4 for each; p Ͼ 0.05 versus vehicle; Fig. 6, B-D) . In these experiments, the pipette solution contained 0.05% DMSO as the solvent even in the control. Similar results were also obtained by the internal addition of 10 M U73122 (n ϭ 5), a PLC inhibitor, which contained 0.05% ethanol as the solvent. These results suggest that the difference in Ca 2ϩ release by the production of IP 3 at Ϫ40 and Ϫ80 mV may be negligible under these experimental conditions, and the decrease in the [Ca 2ϩ ] i induced by the step hyperpolarization may be simply caused by the decrease in Ca 2ϩ influx.
Local Control of the [Ca 2؉ ] i Increase Induced by Membrane Depolarization. Ca 2ϩ images of CASMCs during depolarization from Ϫ80 to 0 mV were analyzed in the same manner as shown in Fig. 4 (Fig. 7) . When the membrane potential was held at Ϫ80 mV for 60 s, the global [Ca 2ϩ ] i was 109 Ϯ 8 nM (n ϭ 6). The depolarization to 0 mV elevated the global [Ca 2ϩ ] i to 387 Ϯ 16 nM, with a rise time constant of 2.8 Ϯ 0.4 s (n ϭ 6). The global [Ca 2ϩ ] i at 0 mV in the peripheral region was not significantly different from that in the central region (p Ͼ 0.05; Fig. 7D ). It is noteworthy that the rise time constant in the peripheral regions (1.3 Ϯ 0.2 s; n ϭ 6) was significantly smaller than in the global areas (n ϭ 6; p Ͻ 0.05) and central areas (2.9 Ϯ 0.4 s; n ϭ 6; p Ͻ 0.05) (Fig. 7E) . It is clear from the time constants and Ca 2ϩ line-scan image in Fig. 7C that the [Ca 2ϩ ] i increase in the peripheral region was faster than that in the central region during membrane depolarization. In Fig. 7C, the possibility that membrane depolarization facilitates IP 3 formation and subsequent Ca 2ϩ release from storage sites was examined by the use of agents suppressing the IP 3 -mediated increase in [Ca 2ϩ ] i . The long depolarization induced a rapid increase in the [Ca 2ϩ ] i from 107 Ϯ 4 nM to a peak of 371 Ϯ 13 nM in control myocytes (n ϭ 8) and from 103 Ϯ 3 to 392 Ϯ 16 nM in 1 mg/ml heparin-treated myocytes (n ϭ 4; p Ͼ 0.05), respectively (Fig. 8, A-C) . The [Ca 2ϩ ] i reached a peak within 5 s of the start of depolarization in both control and heparin-treated cells. The global [Ca 2ϩ ] i was maintained at a high level in the control cells (343 Ϯ 12 nM at 60 s; 90 Ϯ 2% of the peak; n ϭ 8; p Ͼ 0.05 versus the peak). In contrast, the global [Ca 2ϩ ] i declined gradually to a steady level of 224 Ϯ 9 nM within 60 s in the heparin-treated cells (n ϭ 4; p Ͻ 0.01 versus the corresponding peak and also versus the steady level in the control). Heparin reduced the sustained increase in [Ca 2ϩ ] i at 60 s from the start of depolarization to 42 Ϯ 3% of the peak (n ϭ 4). Likewise, the decay of the outward currents in the heparin-treated cells (from 1061 Ϯ 49 pA at the peak to 507 Ϯ 39 pA at 60 s, a 49 Ϯ 5% decrease; n ϭ 8) was significantly faster and larger than that in the control cells (from 1103 Ϯ 40 pA at the peak to 354 Ϯ 37 pA at 60 s, a 32 Ϯ 3% decrease; n ϭ 4; p Ͻ 0.05) (Fig. 8D) .
The effects of 2-APB, U73122, and xestospongin C on [Ca 2ϩ ] i during depolarization were also examined in the same manner. Figure 9 , A and B clearly demonstrates that the [Ca 2ϩ ] i and current amplitude during prolonged depolarization were decreased by 50 M 2-APB and 10 M (Fig. 9C) . The maximum amplitude of the outward currents evoked by depolarization was unaffected by 2-APB and U73122 (n ϭ 4; p Ͼ 0.05; Fig. 9D ). On the other hand, a significant decrease in current amplitude during prolonged depolarization was observed with the internal addition of 2-APB (324 Ϯ 23 pA; n ϭ 4; p Ͻ 0.01 versus vehicle at 529 Ϯ 13 pA) and U73122 (324 Ϯ 34 pA; n ϭ 4; p Ͻ 0.05). A similar time course for the [Ca 2ϩ ] i reduction and current decrease during the prolonged depolarization was observed in the case of an internal application of 10 M xestospongin C (n ϭ 4) containing 0.05% ethanol as the solvent.
The [Ca 2ϩ ] i increase in the step depolarization from Ϫ80 to 0 mV was markedly reduced by the addition of 100 M Cd 2ϩ to the bathing solution (n ϭ 7; p Ͻ 0.01; Fig. 10 ), and the increase was statistically significant. In the presence of heparin in the pipette solution, the addition of Cd 2ϩ significantly reduced the [Ca 2ϩ ] i at both the peak and steady state (n ϭ 7; p Ͻ 0.01). In the presence of Cd 2ϩ , there was no significant difference in [Ca 2ϩ ] i either at the peak or the steady state between the absence and presence of heparin. ] i and the inward current by hyperpolarization from Ϫ40 to Ϫ80 mV were measured in the presence in the pipette solution of 1 mg/ml heparin, a blocker of IP 3 Rs. The step hyperpolarization was applied at least 3 min after the rupture of the patch membrane was performed to make the whole-cell clamp configuration. B and C, the [Ca 2ϩ ] i levels at both Ϫ40 and Ϫ80 mV (B) and the decay time constant (C) were unaffected by heparin. Neither blockers of IP 3 Rs, 50 M 2-APB or 10 M xestospongin C (Xest C) from the pipette solution, affected the [Ca 2ϩ ] i and time constant. Similar results were also obtained by the addition to the pipette solution of 10 M U73122, a PLC inhibitor. D, the amplitudes of the inward current in the absence and presence of an IP 3 pathway inhibitor are summarized. The experimental data were obtained from four to five myocytes. 
Discussion
The present study clearly shows, by simultaneous measurement of the Ca 2ϩ image and electrophysiological signal, that the [Ca 2ϩ ] i is regulated by Ca 2ϩ influx through VDCCs, an effect that is modulated directly by the membrane potential, so that the change in VDCC activity is exerted on [Ca 2ϩ ] i proportionally. The decrease in the [Ca 2ϩ ] i induced by K ϩ channel openers is mainly caused by a reduction of Ca 2ϩ influx resulting from the decrease in VDCC activity mediated by the membrane hyperpolarization in VSMCs. In addition, the sustained increase in [Ca 2ϩ ] i during depolarization is partly caused by the Ca 2ϩ release mediated by the activation of PLC followed by enhanced IP 3 formation in VSMCs (Fig. 11) .
Vascular smooth muscle tone is determined by the [Ca 2ϩ ] i level, which is directly regulated by the membrane potential (Carl et al., 1996) . In the range of Ϫ90 to 0 mV, the L-type Ca 2ϩ current amplitude was enhanced after the depolariza- ] i increase. The possibility that [Ca 2ϩ ] i handling during a long depolarization period was regulated, in part, by the formation of IP 3 was examined under voltage clamp. The Ca 2ϩ images during depolarization from Ϫ80 to 0 mV were obtained by using a pipette solution containing 1 mg/ml heparin. A and B, the depolarization induced a rapid rise of [Ca 2ϩ ] i and the outward current in a heparin-treated myocyte in a similar manner as a control myocyte (A). The Ca 2ϩ images during depolarization in the absence and presence of heparin are shown (B). The global [Ca 2ϩ ] i and outward current were kept at a high level in a control myocyte (ϳ400 nM and ϳ500 pA, respectively). In contrast, the global [Ca 2ϩ ] i and current amplitude declined gradually to a steady level of ϳ250 nM and ϳ350 pA, respectively, within 60 s in a heparin-treated myocyte. C, [Ca 2ϩ ] i at the resting level of Ϫ80 mV and at the peak and steady state of the depolarizing potential at 0 mV are plotted. D, the outward current amplitude at the peak and steady states of the [Ca 2ϩ ] i in the absence and presence of heparin are summarized. The experimental data were obtained from four to eight myocytes. The statistical significance is expressed as ‫,ء‬ p Ͻ 0.05 or ‫,ءء‬ p Ͻ 0.01 versus control. ] i handling during long depolarization was regulated, in part, by IP 3 formation was examined by using 2-APB, U73122, and xestospongin C. A and B, the peak amplitudes of [Ca 2ϩ ] i and the outward current were not affected, but the steady-state level of [Ca 2ϩ ] i and the outward current were reduced by the addition to the pipette solution of 50 M 2-APB (A) or 10 M U73122 (B). C, the effects on [Ca 2ϩ ] i exerted by 2-APB, U73122, and xestospongin C (Xest C) are plotted. A significant decrease in [Ca 2ϩ ] i during prolonged depolarization was observed in the presence of 2-APB, U73122, or 10 M xestospongin C in the pipette solution. D, the outward current amplitudes at peak and steady [Ca 2ϩ ] i levels in the absence and presence of an IP 3 pathway blocker are summarized. The experimental data were obtained from four myocytes for each. The statistical significance is expressed as ‫,ء‬ p Ͻ 0.05 or ‫,ءء‬ p Ͻ 0.01 versus control.
Voltage Dependence of Ca 2؉ and IP 3 Signals tion of the cell membrane and reached a peak at 0 mV . When the VDCC activity was enhanced by the agonist, the depolarization-evoked [Ca 2ϩ ] i was increased compared with the absence of the agonist. On the other hand, the blockade of VDCCs depressed the extent of the [Ca 2ϩ ] i increase (Ͼ80% decrease). These results indicate that the extent of the Ca 2ϩ influx depends on VDCC activity (or the open probability) and the major pathway of the [Ca 2ϩ ] i increment by the membrane depolarization is through the VDCCs.
It is still unclear whether the intracellular Ca 2ϩ mobilization during membrane hyperpolarization is induced by the potentiation of K ϩ channel activities in vascular smooth muscle. It has been suggested that the major mechanism underlying the vasodilating effect of the enhancement of K ATP channel activity may be caused by the decrease in Ca 2ϩ influx through VDCCs by the membrane hyperpolarization in VSMCs, resulting in the decrease in vascular tone (Nelson and Quayle, 1995 ] i distribution and the membrane potential. The results obtained from recordings under both the current-and voltage-clamp modes indicate that the membrane hyperpolarization via the opening of the K ATP channel causes a decrease in Ca 2ϩ influx through VDCCs, which results in the decrease of the smooth muscle tonus to achieve vascular relaxation.
The commonly used K Ca 1.1 channel opener 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619) (Sellers and Ashford, 1994; Holland et al., 1996) has various side effects such as Ca 2ϩ channel inhibition (Edwards et al., 1994; Holland et al., 1996) and Ca 2ϩ release from internal Ca 2ϩ storage sites . Therefore, Evans blue instead of NS-1619 was used, because it is reported to be a K Ca 1.1 channel opener that does not affect other types of ion channels (Hollywood et al., 1998) . The relationship between [Ca 2ϩ ] i decrease and membrane hyperpolarization induced by Evans blue is in agreement with that by levcromakalim, which indicates that the change in [Ca 2ϩ ] i and the membrane potential by the potentiation of K Ca 1.1 channel activity is similar to that resulting from the activation of the K ATP channel. Even though a different K ϩ channel was activated, the extent of the reduction in [Ca 2ϩ ] i was equal. It is possible that drugs that activate the K ϩ channel without Ca 2ϩ chan- ] i increase in the step depolarization from Ϫ80 to 0 mV in the presence of Cd 2ϩ were examined. A, in a control myocyte, the addition of 100 M Cd 2ϩ reduced the [Ca 2ϩ ] i in both the peak and the steady states. In the presence of 1 mg/ml heparin in the pipette solution, the sustained [Ca 2ϩ ] i during long depolarization was lower than that in the control in the absence of Cd 2ϩ . In the presence of Cd 2ϩ there was no difference in the [Ca 2ϩ ] i in either the peak or steady state between the absence or presence of heparin in the pipette solution. B, [Ca 2ϩ ] i before and during long depolarization in the absence and presence of Cd 2ϩ in the control and heparin-treated myocytes is summarized. C, the outward current amplitudes at the peak and steady [Ca 2ϩ ] i levels in the absence and presence of heparin and/or Cd 2ϩ are summarized. The experimental data were obtained from seven myocytes. The statistical significance is expressed as ‫,ءء‬ p Ͻ 0.01 versus in the absence of Cd 2ϩ or between two groups. nel inhibition may have a relaxant effect similar to K ATP channel openers. K ATP channel openers are used in the treatment of angina, hypertension, bronchial asthma, hypersensitive urinary bladder, and other diseases (Edwards and Weston, 1995) . On the other hand, K Ca 1.1 channel openers have not come into use as therapeutic drugs to date, although they are proposed as potential targets in hypertension, urinary incontinence, and erectile dysfunction (Lawson and McKay, 2006; Ledoux et al., 2006) . The blockade of the K Ca 1.1 channels, which are highly expressed in VSMCs (Kuriyama et al., 1998) , results in a membrane depolarization of several millivolts and an increase in muscle tone, so these channels are thought to regulate the resting membrane potential and muscle tone (Nelson and Quayle, 1995) . In addition, it is suggested that the potentiation of K Ca 1.1 channel activity, such as spontaneous transient outward currents and hyperpolarizations, is triggered by local Ca 2ϩ release from the ryanodine receptor (RyR) on the SR, termed a "Ca 2ϩ spark" that contributes to the negative feedback mechanism for the regulation of smooth muscle tone (Bolton and Imaizumi, 1996; Imaizumi et al., 1999; Jaggar et al., 2000; Ohi et al., 2001; Cheng and Lederer, 2008) . The evidence suggests that K Ca 1.1 channel openers as well as K ATP channel openers exert a relaxant effect.
One possible mechanism of Ca 2ϩ sensitization is the activation of the protein kinase C, which is mediated by the formation of diacylglycerol after the activation of PLC by agonists. It is conceivable that the membrane hyperpolarization may inhibit phosphatidylinositol turnover, resulting in a reduction in IP 3 , or the membrane hyperpolarization produced by K ϩ channel openers may affect intracellular Ca 2ϩ stores and suppress only the activity of IP 3 -induced Ca 2ϩ release channels. It is suggested that the membrane potential regulates the membrane-associated enzymatic activity of PLC (Itoh et al., 1992; Ganitkevich and Isenberg, 1993) . Whether IP 3 production depends on membrane potential and the regulation of [Ca 2ϩ ] i was examined in VSMCs by using heparin, which is reportedly a blocker of the IP 3 Rs on the SR. Under voltage-clamp conditions, the internal addition of heparin did not affect the relationship between [Ca 2ϩ ] i and membrane potential (n ϭ 4; p Ͼ 0.05 versus absence of heparin), which indicates that IP 3 production, that is, PLC activity may not have contributed to the regulation of [Ca 2ϩ ] i in this case. In addition, the [Ca 2ϩ ] i during hyperpolarization was not affected by IP 3 production.
Membrane depolarization activates VDCCs and thus induces Ca 2ϩ release via RyRs, a process that is obligatory for excitation-contraction coupling and other physiological responses in skeletal and cardiac muscles. However, depolarization-induced Ca 2ϩ release and its functional significance, as well as the underlying signaling mechanisms of the G protein/PLC/IP 3 -mediated Ca 2ϩ release cascade in VSMCs, are largely unknown. It has been reported that membrane depolarization causes a direct activation of muscarinic M 3 receptors in the absence of exogenous agonists, which causes the activation of G proteins and PLC and subsequent IP 3 generation in mouse tracheal SMCs (Liu et al., 2009 ) as well as in rat basilar arterial SMCs (del Valle-Rodríguez et al., 2003) . In addition, VDCC activation by high K ϩ stimulation and the subsequent metabolic Ca 2ϩ release pathway that involves G protein/PLC activation, IP 3 synthesis, and Ca 2ϩ release from the SR, participates in the sustained arterial contraction in basilar and aortic SMCs (Ferná ndez-Tenorio et al., 2011) . These results indicate that L-type Ca 2ϩ channel activation constitutes the key event that triggers depolarization-dependent metabotropic Ca 2ϩ release from the SR and smooth muscle sensitization through the activation of the RhoA/Rho-associated kinase pathway. These phenomena are independent of the change in the membrane potential itself, or at least the release of Ca 2ϩ from the SR, but they do require the simultaneous activation of VDCCs and the downstream metabotropic pathway with concomitant Ca 2ϩ release (Ferná ndez-Tenorio et al., 2011) .
In this study, we demonstrated that the sustained phase of [Ca 2ϩ ] i increase induced by long depolarization is regulated by IP 3 production via PLC activation, which is different from membrane hyperpolarization. In the presence of IP 3 R blockers, the [Ca 2ϩ ] i level was rapidly increased by depolarization to the same level as in control cells (ϳ400 nM), but the sustained [Ca 2ϩ ] i was gradually reduced by ϳ250 nM within 30 s. Similar results were obtained from myocytes treated with an inhibitor of PLC. These studies disclose that membrane depolarization increases IP 3 production without the need of any stimulation by an agonist and the generated IP 3 is required for the sustained increase in [Ca 2ϩ ] i in VSMCs. In the presence of Cd 2ϩ , long depolarization slightly increased the [Ca 2ϩ ] i , which was apparently lower than that in the presence of heparin alone. These results indicate that the sustained increase in [Ca 2ϩ ] i during long depolarization is mainly caused by the Ca 2ϩ influx resulting from VDCC activation and subsequently evokes Ca 2ϩ release, an effect that is caused by the enhanced formation of IP 3 , in VSMCs.
In conclusion, the [Ca 2ϩ ] i is regulated by the activity of the VDCC, which is linked directly to the membrane potential and [Ca 2ϩ ] i reduction by K ϩ channel openers. It is mainly caused by the decrease of VDCC activity by membrane hyperpolarization via the activation of the K ϩ channel in VSMCs. The initial [Ca 2ϩ ] i elevation triggered by Ca 2ϩ influx though VDCCs and subsequent Ca 2ϩ -induced Ca 2ϩ increase from RyRs on the SR, termed a "Ca 2ϩ hot spot" (Imaizumi et al., 1998; Morimura et al., 2006) , may be primarily responsible for the activation of PLC that is required for IP 3 formation and to maintain the sustained phase of [Ca 2ϩ ] i increase in VSMCs.
